VIH en cifras: Datos, estadísticas y tú

HIV in Numbers: What the Statistics Really Tell Us

HIV, or human immunodeficiency virus, is no longer the medical mystery it was at the beginning of the epidemic. Scientists understand how it spreads, highly effective prevention tools exist, and modern antiretroviral therapy can allow people with HIV to live long, healthy lives. Still, HIV remains a significant public health challenge in the United States and worldwide.

At the end of 2022, an estimated 1.2 million people aged 13 and older were living with HIV in the United States. Roughly 13%about 158,000 peopledid not know they had HIV. That last statistic is especially important because someone cannot begin treatment for an infection they do not know they have.

The encouraging part? HIV prevention and treatment have become remarkably effective. The challenging part? Those benefits are not reaching every population and community equally.

31,800 New Infections vs. 38,000 Diagnoses: Why the Numbers Differ

One of the easiest ways to misunderstand HIV statistics is to assume that a new HIV diagnosis automatically means the person acquired HIV during that same year. It does not.

CDC estimates indicate that approximately 31,800 new HIV infections occurred in the United States in 2022. Meanwhile, surveillance data recorded roughly 38,000 HIV diagnoses during 2022 when the United States and several associated territories were included.

Incidence and diagnosis measure different things

HIV incidence estimates how many people actually acquired HIV during a particular period. HIV diagnoses count people who learned they had HIV during that period.

Imagine someone acquires HIV in late 2020 but does not get tested until 2022. The infection belongs to the 2020 incidence picture, while the diagnosis appears in the 2022 diagnosis statistics. Epidemiology occasionally feels like accounting, except the spreadsheets have much higher stakes.

This distinction also explains why HIV surveillance reports often appear a few years after the calendar year being analyzed. Researchers need time to collect, clean, adjust, and interpret nationwide data.

Who Is Most Affected by HIV in the United States?

HIV can affect anyone. Biology does not check a person’s résumé, ZIP code, income, race, gender, or relationship status before allowing a virus to enter the body. But population-level risk is strongly influenced by sexual networks, access to health care, testing, prevention services, stigma, poverty, insurance coverage, housing stability, and other social factors.

Gay and bisexual men remain disproportionately affected

Gay, bisexual, and other men who have sex with men continue to account for a large share of HIV infections in the United States. CDC estimates indicate that approximately 71% of the 31,800 estimated new infections in 2022 occurred among gay and bisexual men.

This does not mean sexual orientation itself causes HIV. Rather, overlapping factorsincluding the prevalence of HIV within particular sexual networks, barriers to preventive care, stigma, discrimination, and unequal access to PrEPaffect population-level risk.

Racial and ethnic disparities remain substantial

Black Americans accounted for approximately 38% of HIV diagnoses in 2022. AIDSVu reported that the HIV diagnosis rate among Black people was approximately eight times the rate among White people and roughly twice the rate among Hispanic people.

Those differences should not be interpreted as biological differences between racial groups. Public health researchers emphasize structural issues such as unequal health care access, poverty, unstable housing, stigma, limited prevention availability, and differences in access to early testing and treatment.

Women account for about one in five diagnoses

Women sometimes receive less attention in conversations about the HIV epidemic, but HIV remains an important women’s health issue. In 2022, women represented approximately 19% of new HIV diagnoses in the United States. Black women have been particularly disproportionately affected.

The good news is that HIV diagnoses among women fell considerably over the previous decade. Continued progress depends on making testing, PrEP, treatment, reproductive health care, and culturally appropriate services easier to access.

Geography Matters: Why the South Carries a Heavy Burden

HIV is not distributed evenly across the country. In 2022, approximately 52% of HIV diagnoses occurred in the U.S. South. AIDSVu also found that 10 of the 12 states with the highest new-diagnosis rates were located in the South.

The reasons are complex. Rural health care shortages, insurance coverage, poverty, stigma, transportation difficulties, availability of HIV specialists, and access to preventive medication can all influence outcomes.

This is one reason the federal Ending the HIV Epidemic initiative concentrates resources in jurisdictions where HIV transmission has been especially common. Its core public health strategy can be summarized in four verbs: diagnose, treat, prevent, and respond.

HIV Testing: One Small Test, One Very Useful Number

Symptoms cannot reliably tell you whether you have HIV. Some people experience flu-like symptoms shortly after infection; others experience little or nothing noticeable. HIV can then remain clinically quiet for years.

The CDC recommends that everyone between ages 13 and 64 receive an HIV test at least once as part of routine health care. People with ongoing risk factors should generally be tested more often, often at least annually. Some sexually active gay and bisexual men may benefit from testing every three to six months depending on circumstances.

The U.S. Preventive Services Task Force similarly recommends routine HIV screening for adolescents and adults, as well as screening during pregnancy. Early diagnosis matters because starting treatment sooner improves health outcomes while also helping prevent transmission.

Testing has a window period

No HIV test can detect infection immediately after exposure. Different tests have different window periods, so someone tested soon after a possible exposure may need repeat testing. A health professional can recommend the appropriate timing based on the test used and the date of exposure.

If a possible exposure occurred recently, do not simply wait for a future test. Post-exposure prophylaxis, or PEP, must be started within 72 hours of a potential exposure, and the sooner it is started, the better.

PrEP Has Changed the Prevention Equation

One of the biggest advances in HIV prevention is pre-exposure prophylaxis, better known as PrEP. PrEP is medication for people without HIV who want additional protection against acquiring the virus.

When taken or administered as prescribed, PrEP reduces the risk of acquiring HIV through sex by approximately 99%. Oral PrEP has also been shown to reduce HIV risk associated with injection drug use by at least 74% when taken as prescribed.

Prevention choices have expanded beyond daily tablets. Long-acting injectable cabotegravir can be administered every two months after its initial dosing schedule. In June 2025, the FDA also approved lenacapavir for HIV PrEP, introducing a long-acting option designed around twice-yearly dosing.

That matters because the “best” prevention method is not merely the medication with the most impressive clinical-trial graph. It is a safe, appropriate method that a person can realistically use consistently.

PrEP does not prevent other sexually transmitted infections, so condoms, STI screening, vaccination when appropriate, and honest conversations with partners still have jobs. PrEP is excellent, but it has not applied for the position of Entire Sexual Health Department.

HIV Treatment Has Completely Changed the Prognosis

There is currently no broadly available cure for HIV, but antiretroviral therapy, or ART, can stop the virus from reproducing efficiently. Treatment lowers the amount of HIV in the blood, protects the immune system, and dramatically reduces the risk of HIV-related illness.

For many people who start treatment promptly and remain in care, HIV can now be managed as a long-term chronic condition. Modern treatment is one of the reasons that people diagnosed with HIV today may live for decades.

What “undetectable” really means

With effective treatment, a person’s viral load can fall below the level routinely detected by standard laboratory testing. When a person with HIV takes treatment and maintains an undetectable viral load, they have zero risk of sexually transmitting HIV.

This is the science behind U=U: Undetectable Equals Untransmittable.

U=U is more than a catchy public health slogan. It changes relationships, reduces fear surrounding HIV, combats stigma, and demonstrates why treatment is also a powerful form of prevention.

The Viral Suppression Numbers Need Context

Statistics about viral suppression can appear contradictory until you examine the denominator.

Among people with diagnosed HIV in 2022, roughly 65% were virally suppressed. When estimates include everyone believed to have HIVincluding people who have not yet been diagnosedthe national suppression percentage is lower.

Now compare that with the federal Ryan White HIV/AIDS Program. In 2023, approximately 90.6% of Ryan White patients receiving HIV outpatient medical care who had viral-load data achieved viral suppression. More than 576,000 people received services through the program.

The difference demonstrates something important: access to medication alone is not the entire story. Successful HIV care can involve doctors, nurses, pharmacies, insurance assistance, transportation, mental health services, housing support, case management, and help staying engaged with care.

Young Adults Should Pay Attention, Too

HIV is sometimes mistakenly imagined as a disease belonging mainly to an older generation because many people remember the AIDS crisis of the 1980s and 1990s. Current data tell a different story.

More than half of HIV diagnoses reported in 2022 occurred among people ages 13 to 34. Younger adults therefore remain an important population for testing, education, condom access, PrEP awareness, and stigma-free sexual health care.

At the same time, people with HIV are living longer. Almost half of clients served by the Ryan White HIV/AIDS Program are now age 50 or older. HIV medicine increasingly includes not only controlling the virus but also helping patients manage cardiovascular health, cancer screening, bone health, kidney health, mental health, and other issues associated with aging.

The Global Numbers Are Still Enormous

Although this article focuses primarily on U.S. HIV statistics, the global scale deserves perspective. Approximately 40.8 million people worldwide were living with HIV in 2024, according to recent international estimates summarized by KFF. About 1.3 million people acquired HIV during 2024.

Those numbers represent enormous progress compared with the worst years of the epidemic, but they also show why HIV has not disappeared. Treatment availability, diagnosis, stigma, conflict, poverty, health-system capacity, medication access, and prevention funding vary tremendously between countries.

What Do HIV Statistics Mean for You Personally?

Population statistics help governments decide where to put clinics and prevention funding. They should not be used as a personal risk calculator.

A person’s HIV risk depends on individual circumstances: sexual practices, HIV status and viral load of partners, condom use, PrEP use, sharing of injection equipment, recent exposures, and other factors.

Someone from a statistically high-incidence population who uses PrEP consistently may have very strong protection. Meanwhile, someone outside a traditionally highlighted group can still acquire HIV if an exposure occurs. A demographic label is not protective equipment.

A practical HIV prevention checklist

• Know your HIV status through appropriate testing.
• Ask sexual partners about testing and prevention without turning the conversation into a courtroom interrogation.
• Discuss PrEP with a clinician if you could benefit from additional protection.
• Use condoms when appropriate, especially for broader STI protection.
• Never share needles or injection equipment.
• Seek PEP immediately after a significant possible exposure; it must be started within 72 hours.
• If diagnosed with HIV, begin treatment and stay engaged in care.
• Remember U=U: sustained viral suppression prevents sexual transmission.

Real-Life Experiences Behind the HIV Statistics

Statistics become easier to understand when we translate them into situations people may actually experience. The following examples are illustrative composites based on common patterns encountered in HIV testing, prevention, and care rather than stories about specific patients.

Experience 1: “I feel completely fine. Why would I test?”

Imagine a 29-year-old who considers himself healthy. He exercises, rarely visits a doctor, and has never noticed symptoms suggesting HIV. He has had several sexual partners over the previous few years but assumes that anyone with HIV would look or feel sick.

During a routine physical, his clinician suggests HIV screening. His first reaction is surprise: “Do you think I’m high risk?”

But that is exactly why routine screening matters. HIV testing does not need to be an accusation about someone’s behavior. CDC recommends at least one test for everyone ages 13 to 64 because people can live with HIV without obvious symptoms.

A negative result gives him useful information rather than merely relief. His clinician also explains PrEP and STI screening. He leaves knowing more about prevention than he did when he arrived. The appointment was not evidence that something was wrong; it was preventive medicine doing its job.

Experience 2: A positive test does not mean life is over

Now imagine someone receiving a confirmed HIV-positive result. Her first thoughts may come from memories of frightening AIDS images from decades ago. She worries about her future, relationships, work, and whether she will ever be able to have a partner without putting that person at risk.

Modern HIV care changes that conversation dramatically. She starts antiretroviral treatment, attends follow-up appointments, and has her viral load monitored. Over time, treatment suppresses the virus to an undetectable level.

She learns about U=U: maintaining an undetectable viral load means she will not sexually transmit HIV. What initially felt like an uncontrollable medical crisis becomes a chronic condition she manages with treatment, monitoring, and support.

The experience can still be emotionally complicated. Medication does not automatically erase stigma, fear of disclosure, insurance issues, or relationship concerns. That is why comprehensive HIV programs frequently include counseling, case management, transportation assistance, housing support, and other services alongside medical treatment.

Experience 3: Prevention becomes part of normal health care

Consider another person who has a new partner and wants stronger HIV protection. Instead of constantly wondering after every sexual encounter whether something went wrong, he discusses PrEP with a clinician.

They review HIV testing, kidney health where relevant, STI screening, medication options, adherence, and follow-up. Depending on his needs and medical eligibility, prevention might involve an oral medicine or a long-acting injectable option.

That conversation turns HIV prevention from occasional panic into a planned health strategy. It resembles contraception, vaccinations, cholesterol screening, or wearing a seat belt: risk management works considerably better when arranged before the emergency.

Perhaps that is the most useful lesson hidden inside all these HIV numbers. The statistics are not asking anyone to be afraid. They are telling us where opportunities existto test earlier, prevent infections, treat HIV effectively, reduce stigma, and connect more people with care.

Conclusion: Numbers Matter, but Action Matters More

HIV statistics tell a complicated story. More than a million people in the United States are living with HIV, thousands of new infections still occur each year, and substantial racial, geographic, age, and gender disparities remain.

Yet today’s HIV story is also one of extraordinary medical progress. Testing can identify infection early. PrEP can reduce sexual HIV acquisition risk by about 99% when used as prescribed. Antiretroviral therapy can suppress HIV, protect long-term health, and eliminate sexual transmission when an undetectable viral load is maintained.

The most important statistic may therefore be the one you can change. Get tested when appropriate. Learn whether PrEP fits your situation. Seek PEP quickly after a possible recent exposure. If you have HIV, stay connected to treatment. And when talking about HIV, replace outdated fear with current science.

The epidemic is measured in millions, but progress still happens one test, one prescription, one conversation, and one person at a time.